[1]Belenkaya TY, Wu Y, Tang X, et al. The retromer complex influences Wnt secretion by recycling wntless from endosomes to the trans-Golgi network. Dev Cell. 2008; 14(1):120-131.
[2]Franch-Marro X,Wendler F,Guidato S,et al.Wingless secretion requires endosome-to-Golgi retrieval of Wntless/Evi/Sprinter by the retromer complex. Nat Cell Biol. 2008;10(2):170-177.
[3]Pan CL, Baum PD, Gu M, et al.elegans AP-2 and retromer control Wnt signaling by regulating mig-14/Wntless. Dev Cell. 2008;14(1):132-139.
[4]Yang PT,Lorenowicz M,Silhankova M,et al.Wnt signaling requires retromer-dependent recycling of MIG-14/Wntless in Wnt-producing cells. Dev Cell. 2008;14(1):1.
[5]Logan CY,Nusse R.The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol.2004;20:781-810.
[6]Moon RT,Kohn AD,De Ferrari GV, et al,Wnt and beta-catenin signalling:diseases and thera-pies.Nat Rev Genet. 2004;5: 691-701.
[7]Patel MS, Karsenty G. Regulation of bone formation and vision by LRP5. N Engl J Med.2002,346:1572-1574.
[8]Logan CY, Nusse R.The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20: 781-810.
[9]Macsai CE, Foster BK, Xian CJ. Roles of Wnt signaling in bone growth, remodeling, skeletal repair disorders and fracture repair. J Cell Physiol.2008;215:578-587.
[10]Griffiths-Jones S,Grocock RJ,van Dongen S,et al,miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res.2006;34:D140-D144.
[11]Rao TP1, Kühl M.An updated overview on Wnt signaling pathways: a prelude for more.Circ Res. 2010;106(12): 1798-1806.
[12]Kobayashi Y, Maeda K, Takahashi N. Roles ofWnt signalingin bone for mation and resorption. Jpn Dental Sci Rev. 2008; 44(1): 76-82.
[13]PitersE, BoudinE, VanHulW. Wnt sigdaling:Awinfor bone.Arch Biochem Biophys.2008;473(2):112-116.
[14]Wodarz A,Nusse R,Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol.1998;14:59-88.
[15]QU Q, HUANG H, CHEN F, et al. Preliminary study of the role of canonical Wnt signalling pathway in non-Hodgkin’s lymphoma cell lines.TUMOR.2013;33(2):144-149.
[16]Hey PJ,Twells RC,Phillips MS,et al.Cloning of a novel member of the low-density lipoprotein receptor family. Gene. 1998;216(1):103-111.
[17]Tüysüz B,Bursal? A,Alp Z,et al.Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment. Horm Res Paediatr. 2012;77(2): 115-120.
[18]Gong Y, Vikkula M, Boon L, et al. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet, 1996;59(1):146-151.
[19]Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5(LRP5) affects bone accrual and eye develop-ment. Cell. 2001;107(4):513-523.
[20]Yadav VK, Ryu JH, Suda N, et al.Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 2008;135:825-837.
[21]Daugherty RL,Gottardi CJ.Phospho-regulation of Beta-catenin adhesion and signaling functions.Physiology (Bethesda),2007;22:303-309.
[22]Bain G, Muller T, Wang X, et al. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys ReS Comrnun.2003;301(1):84-91.
[23]Rubin MR, Bilezikian JP.Parathyroid Hormone as an anabolic skeletal therapy.Drugs.2005;65:2481-2498.
[24]Pettway GJ, Meganck JA, Koh AJ, et al. Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation.Bone.2008;42:806-818.
[25]O'Shea PJ,Kim DW,Logan JG,et al.Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling. J Biol Chem. 2012;287(21): 17812-17822.
[26]Watanabe K, Ikeda K.Osteoblast differentiation and bone formation. Nippon Rinsho. 2009;67(5):879-886.
[27]Si W, Kang Q, Luu HH. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.J Mol Cell Biol.2006;26(8):2955-2964.
[28]Li HX, Luo X, Liu RX. Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells.Mol CeilEndoerinol.2008;291(1-2): 116-124.
[29]Mbalaviele G, Sheikh S, Stains JP.Beta-catenin and BMP2 synergize to promote osteoblast differentiation and new bone formation.J Cell Biochem.2005;94(2):403-418.
[30]Cho HH, Kim YJ, Kim SJ, et al.Endogenous Wnt signaling promotes proliferation and suppre sses osteogenic differentiation in human adipose derived stromal cells. Tissue Eng.2006;12:111-121.
[31]Takada I, Mihara M, Suzawa M, et al. A histonely sinemet hyltransferase activ ated by non-canonical Wnt signaling suppresses PPAR-gamma transac ivation. N ature Cell Biology. 2007;9(11):1273-1285
[32]龙祥,周栓虎,Julie Glowacki. WNT激活剂促迸人骨髓基质干细胞向软骨细胞分化的研究[J].中华实验外科杂志,2010,27(2): 242-244.
[33]Zhou S, Greenberger JS, Epperly MW, et al. Age•related intrinsic changes in human hone-marrow. derived mesefl hymal stem cells andtheir differentiation to osteoblasts.Aging Cell.2008;7:335-343.
[34]Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate ofmesenehymal stem cells. Gene. 2009;433:1-7.
[35]Robinson JA, Chatterjee-Kishore M, Yaworsky PJ,et al. Yaworsky Wnt/ -Catenin Signaling Is a Normal Physiological Response to Mechanical Loading in Bone. J Biol Chem. 2006; 281(42):31720-31728.
[36]Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002;157(2):303-314.
[37]Glass 2nd DA, Bialek P, Ahn JD, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental cell.2005;8(5):751-753.
[38]Redda SJ,McMahon AP.Distinct roles for Hedgehog and canonical Wntsignating in specification,differentia-tion and maintenance of osteoblast progenitorsm. Deve-lopment. 2006;133(16):3231-3244.
[39]Akhter MP, Wells DJ, Short SJ, et al. Bone biomechanical properties in LRP5 mutant mice. Bone.2004;35(1):162-169.
[40]Bodine PVN,Zhao W,Kharode YP,et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol. 2004; 18(5):1222-1237.
[41]Holmen SL,Zylstra CR,Mukherjee A, et al.Essential role of beta-catenin in postnatal bone acquisition.J Biol Chem. 2005; 280:21162-21168.
[42]Bennett CN, Longo KA, Wright WS, et al.Regulation of osteoblastogenesis and bone mass by Wnt10b. Proceedings of the National Academy of Sciences of the United States of America.2005;102(9):3324-3329.
[43]Kobayashi Y, Maeda K, Takahashi N.Roles of Wnt signalingin bone for mation and resorption. Jpn Dental Sci Rev.2008; 44(1): 76-82.
[44]Buffer JS, Queally JM, Devitt BM, et al. Silencing Dkkl expressian rescues dexamethasone-indueed suppression of primary human esteoblast differentiation.BMC Musculoskelet Disord.20l0;15:210.
[45]Xiao CY, Pan YF, Guo XH, et al. Expression of β-catenin in rheumatoid arthritis fibroblast-like synoviocytes. Seand J Rheumatol.2011;40:26-33.
[46]Sehett G, Zwerina J, David JP. The role of Wnt proteins inamlritis. Nat Clin Praet Rheumatol.2008;4:473-480.
[47]Agholme F, Li X•lsaksson H, et al. Sclerostin antibody treatment enhances metaphysesl bone healing in rats. J Bone MinerRes.2010;25:2412-2418.
[48]Lee JH, KimBG, Aim JM, et al. Role of PI3K on the regulation of BMP2-induced beta-Catenin aetivation in human bone marrow stem cells.Bone.2010;46:1522-1532.
[49]Zhang Y, Wang Y, Li X, et al.The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd.Cell Biol.2004;24:4677-4684.
[50]Chamorro MN, Schwartz DR, Vonica A,et al.FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.EMBO J. 2005;24: 73-84.
[51]Sutherland MK, Geoghegan JC, Yu C, et al.Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.Bone.2004;35:828-835. |